Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

RVMD Q1 2019 Earnings — Revolution Medicines, Inc. Revenue & Financial Results | Market Cap Arena

RVMDRevolution Medicines, Inc.

$19B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M

Gross Profit

$13M100.0% margin

Operating Income

-$10M-79.3% margin

Net Income

-$10M-76.9% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+27.2%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$403,000

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$97M

Cash & Equivalents

-$70M

← FY 2019 All Quarters Q2 2019 →